精华制药(002349.SZ)：目前玛巴洛沙韦的工艺优化工作尚在推进中

Group 1 - The core point of the article is that Jinghua Pharmaceutical (002349.SZ) is currently advancing the process optimization work for Mabalosavir [1] Group 2 - The company has communicated this update through an investor interaction platform [1]